Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$12.90
-4.7%
$12.88
$12.00
$18.68
$80.12M116,145 shs103,032 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$1.69
+2.4%
$1.29
$0.87
$7.89
$82.77M0.1306,520 shs123,471 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.46
-4.3%
$4.61
$4.01
$9.33
$73.57M1.3212,037 shs232,407 shs
Vaso Co. stock logo
VASO
Vaso
$0.13
+6.2%
$0.13
$0.11
$0.32
$23.71M1.5589,598 shs5,500 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
0.00%+4.12%+5.31%-20.62%-20.71%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.00%+6.24%+38.52%+6.96%-76.36%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-0.67%-2.83%-19.06%-27.36%
Vaso Co. stock logo
VASO
Vaso
0.00%-0.44%+3.77%+5.14%-43.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
1.8561 of 5 stars
0.05.00.00.01.90.81.9
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.7795 of 5 stars
3.52.00.00.02.01.70.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.8777 of 5 stars
3.62.00.00.01.10.01.3
Vaso Co. stock logo
VASO
Vaso
0.4794 of 5 stars
0.03.00.00.00.81.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3.00
Buy$11.00550.89% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$13.00191.48% Upside
Vaso Co. stock logo
VASO
Vaso
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VASO, FONR, GUTS, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
(Data available from 5/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$101.57M0.79$2.70 per share4.78$25.62 per share0.50
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$93K890.01N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.76$0.05 per share96.29$2.98 per share1.50
Vaso Co. stock logo
VASO
Vaso
$83.05M0.29$0.03 per share4.29$0.14 per share0.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2511.22N/A7.68%4.94%3.70%5/21/2025 (Estimated)
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$77.09M-$1.85N/AN/AN/A-64,849.48%N/A-57.21%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.4011.1519.39N/A15.90%12.60%11.38%N/A
Vaso Co. stock logo
VASO
Vaso
$4.80MN/A0.00N/A-0.14%-0.45%-0.16%N/A

Latest VASO, FONR, GUTS, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/15/2025Q1 2025
Vaso Co. stock logo
VASO
Vaso
N/A-$0.01N/A-$0.01N/A$19.46 million
5/13/2025Q1 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.49-$0.49N/A-$0.49N/AN/A
3/31/2025Q4 2024
Vaso Co. stock logo
VASO
Vaso
N/A$0.01N/A$0.01N/A$27.04 million
3/3/2025Q4 2024
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.44-$0.52-$0.08-$0.52N/AN/A
2/19/2025Q2 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.29N/A$0.29N/A$24.95 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.60
5.58
5.57
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89
Vaso Co. stock logo
VASO
Vaso
N/A
1.42
1.39

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Vaso Co. stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
1.55%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
9.40%
Vaso Co. stock logo
VASO
Vaso
44.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
4806.21 million6.19 millionNot Optionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
10248.98 millionN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.50 million14.85 millionOptionable
Vaso Co. stock logo
VASO
Vaso
260175.74 million97.51 millionNot Optionable

Recent News About These Companies

Top Analyst Reports for Apple, Philip Morris & Sony
Inflammation during menstrual cycle may trigger VOEs: Study
Vasomedical reports Q4 revenue $27M vs. $21.9M last year
Incidence of sickle cell disease complications rise in cold weather

New MarketBeat Followers Over Time

Media Sentiment Over Time

FONAR stock logo

FONAR NASDAQ:FONR

$12.90 -0.64 (-4.73%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$13.00 +0.09 (+0.74%)
As of 05/16/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$1.69 +0.04 (+2.42%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$1.67 -0.02 (-1.18%)
As of 05/16/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.46 -0.20 (-4.29%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$4.42 -0.04 (-1.01%)
As of 05/16/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Vaso stock logo

Vaso OTCMKTS:VASO

$0.13 +0.01 (+6.22%)
As of 05/16/2025 03:59 PM Eastern

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.